Bionomics Limited Announces Pricing of Initial Public Offering in the United States Dec 16, 2021 06:00AM
U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders Dec 1, 2021 06:00AM
Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States Nov 23, 2021 06:37AM
Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2 Social Anxiety Disorder PREVAIL Study Nov 1, 2021 06:00AM
Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial Sep 20, 2021 06:00AM